Nicholas Augustinos joins DexCom's board
This article was originally published in Clinica
Glucose monitoring firm DexCom (San Diego, California) has appointed Nicholas Augustinos to its board of directors. He has over 20 years' experience in healthcare, and currently works for Cisco Systems as senior director of the global healthcare solutions unit. Before this, Mr Augustinos was employed by Computer Sciences Corporation as a partner and senior strategic consulting expert for global health services. He is also on the board of the Continua Alliance, a non-profit coalition of healthcare and technology companies aiming to improve the quality of personal healthcare.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.